The burden of cancers associated with HIV in the South African public health sector, 2004–2014: a record linkage study

[1]  P. Tshering.  Health Financing , 2021, Bhutan Health Journal.

[2]  W. Visser,et al.  An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa , 2020, Journal of skin cancer.

[3]  C. H. Dao Ostinelli,et al.  International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019 , 2020, BMJ Open.

[4]  E. Engels,et al.  Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. , 2017, The lancet. HIV.

[5]  M. Fox,et al.  Changing the South African national antiretroviral therapy guidelines: The role of cost modelling , 2017, PloS one.

[6]  M. Egger,et al.  Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study. , 2017, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[7]  T. Maurer,et al.  Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa , 2016, Journal of acquired immune deficiency syndromes.

[8]  D. Celentano,et al.  Does marital status matter in an HIV hyperendemic country? Findings from the 2012 South African National HIV Prevalence, Incidence and Behaviour Survey , 2016, AIDS care.

[9]  Jennifer R. Rider,et al.  Cancer Incidence following Expansion of HIV Treatment in Botswana , 2015, PloS one.

[10]  M. Egger,et al.  HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study , 2015, BMC Cancer.

[11]  B. Chi,et al.  Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Study , 2014, Journal of acquired immune deficiency syndromes.

[12]  M. Egger,et al.  Kaposi's Sarcoma in HIV‐infected patients in South Africa: Multicohort study in the antiretroviral therapy era , 2014, International journal of cancer.

[13]  L. Bekker,et al.  Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-Infected and HIV-Uninfected Adolescent Females in South Africa , 2014, Infectious diseases in obstetrics and gynecology.

[14]  Yen S. Low,et al.  Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art , 2014, Drug Safety.

[15]  D. Labadarios,et al.  South African National HIV Prevalence, Incidence and Behaviour Survey, 2012 , 2014 .

[16]  R. Newson.  Attributable and Unattributable Risks and Fractions and other Scenario Comparisons , 2013 .

[17]  D. Parkin,et al.  Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010 , 2013, International journal of cancer.

[18]  M. Magoni,et al.  Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era. , 2013, AIDS research and human retroviruses.

[19]  W. Jordan,et al.  HIV testing practices among black primary care physicians in the United States , 2013, BMC Public Health.

[20]  D. Klein,et al.  HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[21]  J. Goedert,et al.  Cancer burden in the HIV-infected population in the United States. , 2011, Journal of the National Cancer Institute.

[22]  Nazim Madhavji,et al.  Organization , 2020, WER.

[23]  Charles R. Thomas,et al.  HIV- positive anal cancer: an update for the clinician. , 2010, Journal of gastrointestinal oncology.

[24]  E. Lanoy,et al.  Skin cancers associated with HIV infection and solid‐organ transplantation among elderly adults , 2010, International journal of cancer.

[25]  A. Sasco,et al.  The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa , 2010, PloS one.

[26]  Kurt Straif,et al.  A review of human carcinogens--Part F: chemical agents and related occupations. , 2009, The Lancet. Oncology.

[27]  A. Justice,et al.  Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression , 2009, Journal of acquired immune deficiency syndromes.

[28]  K. H. Hullsiek,et al.  Cutaneous malignancies among HIV-infected persons. , 2009, Archives of internal medicine.

[29]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[30]  S. Franceschi,et al.  Pattern of cancer risk in persons with AIDS in Italy in the HAART era , 2009, British Journal of Cancer.

[31]  K. H. Hullsiek,et al.  Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study , 2009, AIDS.

[32]  Naho.  HIV/AIDS – A fact sheet , 2009 .

[33]  V. Beral,et al.  The spectrum of human immunodeficiency virus‐associated cancers in a South African black population: Results from a case–control study, 1995–2004 , 2008, International journal of cancer.

[34]  M. Falster,et al.  Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis , 2007, The Lancet.

[35]  D. Parkin,et al.  Spectrum of cancers among HIV‐infected persons in Africa: The Uganda AIDS‐Cancer Registry Match Study , 2006, International journal of cancer.

[36]  F. Sitas,et al.  Kaposi's sarcoma in South Africa. , 2000, Journal of the National Cancer Institute. Monographs.